Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.

ABSTRACT:

Importance

Prescription drug spending is a topic of increased interest to the public and policymakers. However, prior assessments have been limited by focusing on retail spending (Part D-covered drugs), omitting clinician-administered (Part B-covered) drug spending, or focusing on all fee-for-service Medicare beneficiaries, regardless of their enrollment into prescription drug coverage.

Objective

To estimate the proportion of health care spending contributed by prescription drugs and to assess spending for retail and clinician-administered prescriptions.

Design, setting, and participants

Descriptive, serial, cross-sectional analysis of a 20% random sample of fee-for-service Medicare beneficiaries in the United States from 2008 to 2019 who were continuously enrolled in

SUBMITTER: Dusetzina SB 

PROVIDER: S-EPMC9579917 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature